Acne Scrub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. It assists in combating breakouts effectively.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects mentioned.

Dosage and Administration

The product is to be used up to twice daily. Prior to application, the face should be wet. The recommended method involves applying the product to the hands, adding water, and working it into a lather. The lather should then be gently massaged onto the face. After massaging, it is essential to rinse the face thoroughly with water. Care should be taken to avoid contact with the eyes; in the event of contact, the eyes should be flushed thoroughly with water.

Contraindications

There are no specific contraindications identified for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. This product is intended solely for topical application and should not be ingested.

Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. It is advisable to limit the use of topical acne treatments to one at a time to minimize the risk of irritation.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

No specific instructions for discontinuation were provided; however, healthcare professionals should remain vigilant for any adverse reactions and advise patients to consult their physician if they experience significant discomfort or unexpected side effects.

Side Effects

Patients should be aware that the product is intended for external use only. Adverse reactions associated with the use of this product may occur, although specific adverse reactions have not been detailed in the provided information.

For any inquiries or to report adverse reactions, patients can contact the information line at 1-888-287-1915 or visit Walmart.com/help. The product is distributed by Walmart Inc., located in Bentonville, AR 72716, and is made in the USA with both domestic and imported ingredients.

It is important to note that the product is packaged in a plastic tube, which should not be recycled, as indicated by the recycling guidelines available at how2recycle.info.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

The medication may be used in pediatric patients up to twice daily, as directed. Caregivers should ensure that the dosage is appropriate for the child's age and condition.

Geriatric Use

Elderly patients may not have specific dosage adjustments or safety concerns outlined in the prescribing information for Acne Scrub (salicylic acid gel). As there is no dedicated information regarding the use of this medication in geriatric populations, healthcare providers should exercise caution when prescribing to elderly patients.

It is advisable to monitor this demographic closely for any potential adverse effects, given the general considerations for increased sensitivity to medications in older adults. Further clinical judgment should guide the use of this product in patients aged 65 and older, taking into account their overall health status and any concurrent medications.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal impacts associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that pregnant patients discuss their treatment options with their healthcare provider to ensure informed decision-making regarding their health and the health of the fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants from the use of this product during lactation.

Renal Impairment

Patients with renal impairment may require dosage adjustments to ensure safety and efficacy. It is essential to monitor renal function tests in individuals with kidney problems to assess their renal status. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects associated with impaired renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, as the lack of data may impact the safety and efficacy of treatment in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include alterations in consciousness, respiratory distress, cardiovascular instability, and other systemic effects.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and clinical status, and initiate supportive care as necessary. It is crucial to obtain a detailed history of the substance involved, including the amount and route of administration, to guide further management.

Management procedures may include the administration of activated charcoal if the patient presents within a suitable timeframe and is not at risk of aspiration. In cases of severe toxicity, specific antidotes may be indicated, and consultation with a poison control center or a medical toxicologist is advised.

Continuous monitoring of the patient’s condition is essential, and healthcare providers should be prepared to implement advanced life support measures if indicated. Documentation of the incident and the management steps taken is also critical for ongoing patient care and legal considerations.

In summary, while no specific overdosage information is provided, healthcare professionals should maintain a high index of suspicion and be prepared to act swiftly in the event of an overdose scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication concurrently with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. This guidance is essential for ensuring the safe and effective use of the medication.

Storage and Handling

The product is supplied in a tube format. It is essential to store the tube at room temperature, ensuring that it is not exposed to freezing conditions. To maintain the integrity of the product, the tube should be kept in an upright position. Once opened, the product must be discarded and should not be recycled.

Additional Clinical Information

The medication is administered topically and may be used up to twice daily. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, it is important to flush the eyes thoroughly with water.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Acne Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)